Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance

Rebecca T Hahn; Susheel Kodali; Philippe Généreux; Martin Leon

doi:10.1007/s11886-014-0475-6

Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance

Curr Cardiol Rep. 2014 May;16(5):475. doi: 10.1007/s11886-014-0475-6.

Authors

Rebecca T Hahn¹, Susheel Kodali, Philippe Généreux, Martin Leon

Affiliation

¹ Columbia University Medical Center, New York-Presbyterian Hospital, 177 Fort Washington Avenue, New York, NY, 10032, USA, [email protected].

PMID: 24633646
DOI: 10.1007/s11886-014-0475-6

Abstract

Despite the higher incidence of paravalvular regurgitation (PVR) with transcatheter aortic valve replacement (TAVR), this novel treatment modality has rapidly emerged as a reasonable alternative to surgical aortic valve replacement (SAVR) in high risk and inoperable patients. This review will discuss the current literature with respect to assessment, outcomes, predictors, and intraprocedural treatment options of PVR following TAVR. Understanding the predictors may help reduce the incidence of PVR and improving the outcome of this procedure.

Publication types

Review

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / physiopathology*
Aortic Valve Insufficiency / diagnostic imaging
Aortic Valve Insufficiency / mortality
Aortic Valve Insufficiency / physiopathology
Aortic Valve Insufficiency / surgery*
Aortic Valve Stenosis / mortality
Aortic Valve Stenosis / physiopathology
Aortic Valve Stenosis / surgery*
Echocardiography, Doppler, Color
Female
Heart Valve Prosthesis Implantation / adverse effects*
Heart Valve Prosthesis Implantation / methods
Humans
Incidence
Male
Postoperative Complications / diagnostic imaging
Postoperative Complications / surgery
Predictive Value of Tests
Reoperation
Risk Factors
Treatment Outcome